Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

• Status: Completed
• Trial end date: 2020-01-03
• Target enrollment: 0
• Participant gender: All

Summary

Acute headache is one of the most common reasons for presentation to the emergency department (ED), accounting for 2-3% of all emergency visits. Migraine is a disorder of the central nervous system characterized by a moderate or severe headache, which is generally associated with nausea and/or sensitivity to light and sound, interfering with daily activities.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Adiyaman University Research Hospital
• Treatments: Dexketoprofen trometamol; Ketoprofen; Metoclopramide

Criteria

Inclusion Criteria:

-Patients aged 18 and over with acute headache who met the diagnostic criteria of the International Headache Association (9) for the diagnosis of migraine

Exclusion Criteria:

• Patients who refused to participate in the study

• Patients that took any analgesic medication within six hours before presentation to ED Patients with any additional organic pathology (e.g., hypertension, hypoglycemia, chronic kidney failure, and intracranial masses) pregnant women hemodynamically unstable patients patients with an allergy to the drugs used in the study